Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Risperdal Lawsuits Allege Drug Is Linked to Gynecomastia, Male Breast Growth  Join our daily free Newsletter

MENAFN Press - 19/02/2014
No. of Ratings : 0
Add to Mixx!



(MENAFN Press) (EMAILWIRE.COM, February 19, 2014 ) New York, NY -- In light of allegations that the antipsychotic drug Risperdal can cause abnormal breast growth in boys, the attorneys working with ClassAction.org are offering free case reviews to patients who suffered adverse effects after using the drug, as well as loved ones acting on their behalf. Lawsuits allege that Janssen Pharmaceuticals, the maker of Risperdal, knew its antipsychotic drug could put boys at risk for developing breasts (a condition known as gynecomastia), yet failed to properly warn the public about this side effect. If you or someone you know developed gynecomastia after using Risperdal, you may have legal recourse. For more information, visit http://www.classaction.org/risperdal



In 2006, the FDA approved Risperdal for use in adolescents; however, lawsuits filed against Janssen allege that the company participated in ghostwriting campaigns to promote Risperdal for off-label uses, specifically in adolescents, long before FDA approval. According to one lawsuit, a young boy began using Risperdal in 1997 at the age of six and developed gynecomastia after using the antipsychotic drug for nearly four years. In addition to abnormal breast growth, lawsuits claim that Risperdal users suffered from other serious side effects, including problems with their endocrine systems and sexual organs. Plaintiffs allege that despite knowing that Risperdal could put boys at risk for developing gynecomastia, Janssen concealed its knowledge and continued to market the drug as a safe and effective antipsychotic



According to the current prescribing information* for Risperdal, more than two percent of clinical trial patients developed gynecomastia after using the antipsychotic. Some believe that Risperdal may cause gynecomastia because it increases levels of a hormone known as prolactin in the body, which is only found naturally in breastfeeding women. Several studies have linked Risperdal to heightened levels of prolactin. In 2006, researchers found that when Risperdal was administered to adolescents at doses commonly used for the treatment of psychotic treatments, it could greatly increase prolactin levels. Another study from 2009 found that heightened levels of prolactin remained in patients' bodies for at least two years after ceasing use of Risperdal.



Court documents indicate that Janssen had a duty to provide safe prescription drugsor proper and adequate warnings of risks and side effects associated with its drugs, including Risperdal. If you or someone you know suffered from gynecomastia after using Janssen's antipsychotic, you may be entitled to compensation. For more information on your potential legal rights, please Click here.



About ClassAction.or



Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit ClassAction.org today for a no cost, no obligation case evaluation and information about your consumer rights.



*http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020272s056,020588s044,021346s033,021444s03lbl.pdf

ClassAction.or

Jodie Car

908-222-884

pressrelease@lawyercentral.com This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php. Source: EmailWire.Com



About EmailWire.com

 


MENAFN Press




  MENA News Headlines
 Oct 21 2014 - Kuwait Stock Exchange Closes on Red NoteQatar News Agency
(MENAFN - QNA) Kuwait Stock Exchange (KSE) ended Tuesday's trading session in the red zone as weighted index read 482.16 (-2.45 points), KSX 15 index at 1,175.79 (-7.15 points) and the price index ...

 Oct 21 2014 - Qatar- Transport Minister Leaves for EgyptQatar News Agency
(MENAFN - QNA) HE Minister of Transport Jassim Saif Al Sulaiti left Doha Tuesday heading to Egypt to preside over the 27th session of the Arab transport ministers' meeting, which will be held at the ...

 Oct 21 2014 - Qatar- HH the Emir Ratifies Agreement with ArgentineQatar News Agency
(MENAFN - QNA) HH the Emir Sheikh Tamim bin Hamad Al-Thani issued Tuesday Decree No. 44 of 2014 ratifying an agreement establishing a joint commercial ministerial committee between the government of ...

 Oct 21 2014 - Qatar- HH the Emir Meets Turkish Interior MinisterQatar News Agency
(MENAFN - QNA) HH the Emir Sheikh Tamim bin Hamad Al-Thani met here Tuesday morning in his Emiri Diwan office with Turkish Interior Minister Avkan Alaa and his accompanying delegation on the ...

 Oct 21 2014 - Qatar- Attorney General Meets French Education MinisterQatar News Agency
(MENAFN - QNA) HE the Attorney General Dr Ali bin Fetais Al Marri met here today with French Education Minister Najat Vallaud-Belkacem. During the meeting they discussed ways to strengthen and ...

 Oct 21 2014 - Qatar- HH the Emir Ratifies Education MoU with CyprusQatar News Agency
(MENAFN - QNA) HH the Emir Sheikh Tamim bin Hamad Al-Thani issued Tuesday Decree No. 45 of 2014 ratifying a Memorandum of Understanding in the field of education between the governments of the State ...

 Oct 21 2014 - Qatar- HH the Emir Ratifies Cooperation Agreement with MoroccoQatar News Agency
(MENAFN - QNA) HH the Emir Sheikh Tamim bin Hamad Al-Thani issued Tuesday Decree No. 46 of 2014 ratifying a cooperation agreement between the governments of the State of Qatar and the Kingdom of ...

 Oct 21 2014 - Qatar- HH the Emir Appoints Ambassador to Azerbaijan /Local Press/Qatar News Agency
(MENAFN - QNA) HH the Emir Sheikh Tamim bin Hamad Al-Thani on Tuesday issued Emiri Decision No. 80 of 2014 appointing Sayar Abdulrahman Jassim Al Mauda as Ambassador Extraordinary and ...

 Oct 21 2014 - Qatar- Real Estate Transactions Worth over QR655 Million Last WeekQatar News Agency
(MENAFN - QNA) Real estate transactions between October 12 and 16 for the real estate sales contracts registered at the Ministry of justice are worth QR655,303,640, the real estate registration ...

 Oct 21 2014 - Qatar- Plastic, Printing and Packaging Expo Opens SundayQatar News Agency
(MENAFN - QNA) Qatar Plastic, Printing and Packaging (QPPP) exhibition opens at the Qatar National Convention Centre (QNCC) October 26. The three-day expo will showcase manufacturing processes, ...

more...


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help